Pneumocytes type II ultrastructural modifications after storage in preservation solutions for transplantation

European Surgical Research

Volumn 29, Issue 5, 1997, Pages 319-326

  Carbognani, Paolo ^a   Rusca, M ^a   Solli, P ^a   Spaggiari, L ^a   Alessandrini, Francesca ^a   Ferrari, C ^b   Cattelani, L ^a   Dal Corso, H ^a   Bobbio, P ^a  

^a Departments of Thoracic and Vascular Surgery   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Lung preservation; Lung transplantation; Pneumocytes type II; Storage solution

Indexed keywords

DEXTRAN; POTASSIUM; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; AGED; ARTICLE; CELL DAMAGE; CELL ULTRASTRUCTURE; CELL VIABILITY; FEMALE; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS CELL TYPE 2; LUNG TRANSPLANTATION; MALE; ORGAN PRESERVATION; PRIORITY JOURNAL; TIME;

EID: 0030928161     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129539     Document Type: Article

References (14)

1. Novik RJ, Menkis AH, McKenzie FN: New trends in lung preservation: A collective review. J Heart Lung Transplant 1992;11:337-392.
2. Belzer FO, Southard JH: Principles of solid-organ preservation by cold storage. Transplantation 1992:45: 673-676.
3. Christie NA, Waddel TK: Lung preservation; in Patterson GA, Cooper JD (eds): Chest Surgery Clinics of North America: Lung Transplantation. Philadelphia, Saunders. 1993, pp 27-41.
4. Maccherini M, Keshavjcc SH, Slutsky AS, Patterson GA, Edelson JD: The effect of flow potassium dcxtran versus Euro-Collins solution for preservation of isolated type II pneumocytes. Transplantation 1991;52:621-626.
5. Hooper TL, Jones MT, Thomson DS, Cook L, Owen S, Wilkes S, Woodcock A, Webster AH, Hasle-ton P, McGregor CG: Hypertonic citrate solution as an alternative to modified Euro-Collins solution for lung preservation. Transplantation 1991;51:1043-1048.
6. Tcdy G, Corbi P, Rabago G, Munc-rctto C, Pavie A, Chomette G, Ca-brol C, Gandjbakhch I: Comparison of blood-based and crystalloid cardiopneumoplegic solutions in heart and lung preservation for 24 hours: An ultrastructural morpho-mctric study in dogs. Transplant Proc 1993:25:2222-2225.
7. Alessandrini F, Thakkar M, Foda HD, Said SI, Lodi R, Pakbaz H, Schraufnagel DE: Vasoactive intestinal peptide enhances lung preservation. Transplantation 1993;56: 964-973.
8. Fehrenbach H, Hirt SW, Wahlers T, Schnabel PA, Haverich A, Richter J: Euro-Collins flush perfusion in human lung preservation - ultrastructural studies of the preservation quality of the contralateral donor lung in clinical single lung transplantation. J Heart Lung Transplant 1994;13:1-14.
9. Will BM, Wahlers T, Fehrenbach H, Hirt SW, Haverich A, Richter J: Human lung preservation with Euro-Collins solution: Early postoperative transplant function correlates with ultrastructural alterations of the contralateral donor lung. Transplant Proc 1995:27:1997-1999.
10. Reynolds ES: The use of lead citrate at high pH as an clcctronpaquc stain in electron microscopy. J Cell Biol 1963;17:208-212.
11. Carbognani P, Spaggiari L, Rusca M, Cattelani L, Solli P, Romani A, Alessandrini F, Dell'Abate P, Va-lente M, Bobbio P: Pulmonary endothelial cell modifications after storage in solid-organ preservation solutions. J Int Med Res 1995:23: 200-206.
12. Patterson GA, Cooper JD: Lung transplantation; in Pearson FG, Deslauliers J. Ginsberg RJ. Hiebert CA. McNeally MF. Urschel HC Jr (eds): Thoracic Surgery. Edinburgh, Churchill Livingstone. 1995, pp 931-959.
13. Hardesty RL, Aeba R, Armitagc JM: A clinical trial of University of Wisconsin solution for pulmonary preservation. J Thorac Cardiovasc Surg 1991;105:660-666.
14. Detterbeck FC, Keagy BA, Pauli DE: Oxygen free radical scavengers decrease rcpcrfusion injury in lung transplantation. Ann Thorac Surg 1990;50:204-210.